Stock IZO IZOTROPIC CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Izotropic Corporation Share Price

Equities

IZO

CA46604F1099

Advanced Medical Equipment & Technology

Market Closed - Canadian Securities Exchange
Other stock markets
 12:32:11 27/04/2024 am IST 		5-day change 1st Jan Change
0.14 CAD +16.67% Intraday chart for Izotropic Corporation +12.00% +40.00%
02/04 Izotropic Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
30/01 Izotropic Corporation Receives Response from U.S. FDA CI

Financials

Sales 2022 - Sales 2023 - Capitalization 17.89M 24.45M 1.49B
Net income 2022 -6M -8.2M -500M Net income 2023 -5M -6.83M -417M EV / Sales 2022 -
Net Debt 2022 172K 235K 14.31M Net Debt 2023 1.97M 2.7M 165M EV / Sales 2023 -
P/E ratio 2022
-4.47 x
P/E ratio 2023
-3.05 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 89.73%
More Fundamentals * Assessed data

Chart Izotropic Corporation

Dynamic Chart

Latest news about Izotropic Corporation

Izotropic Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
Izotropic Corporation Receives Response from U.S. FDA CI
Izotropic Corporation Provides an Update on its Regulatory Status with the U.S. Food and Drug Administration and Operational Activities CI
Izotropic Corporation Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023 CI
Izotropic Corporation Reports Earnings Results for the First Quarter Ended July 31, 2023 CI
Izotropic Corporation Confirms Fda Pre-Submission Meeting Date with U.S. Food and Drug Administration CI
Izotropic Corporation Files Class II Pre-Submission with FDA & Releases Details on Predicate Devices CI
Izotropic Corporation announced that it has received CAD 0.710331 million in funding CI
Izotropic Corporation announced that it expects to receive CAD 0.5 million in funding CI
Izotropic Corporation Reports Earnings Results for the Full Year Ended April 30, 2023 CI
Izotropic Corporation Announces Resignation of John McGraw as Board of Directors CI
Izotropic Corporation Announces John McGraw Has Resigned as Chief Executive Officer CI
Izotropic Corporation Completes Sub Submission with Fda Regarding Clinical Study CI
Izotropic Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023 CI
Izotropic Corporation Announces CFO Changes CI
More news

Press releases Izotropic Corporation

Izotropic Receives Response From U.S. FDA NE
Izotropic Provides Regulatory and Operational Updates NE
Izotropic Provides Regulatory and Operational Updates AQ
Izotropic Announces AGM Results AQ
Izotropic Completes Pre-Submission Meeting with U.S. FDA NE
More press releases

News in other languages on Izotropic Corporation

Izotropic erhält Antwort von der US-Behörde FDA
Izotropic erhält Antwort von der US-Behörde FDA
Izotropic erhält Antwort von der US-Behörde FDA
Izotropic gibt Updates zu regulatorischen und betrieblichen Themen
Izotropic gibt Updates zu regulatorischen und betrieblichen Themen
More news

Quotes and Performance

1 day+16.67%
1 week+12.00%
Current month+12.00%
1 month+16.67%
3 months+3.70%
6 months-28.21%
Current year+40.00%
More quotes

Highs and lows

1 week
0.11
Extreme 0.11
0.14
1 month
0.11
Extreme 0.11
0.15
Current year
0.10
Extreme 0.1
0.22
1 year
0.10
Extreme 0.1
0.40
3 years
0.10
Extreme 0.1
1.27
5 years
0.10
Extreme 0.1
1.56
10 years
0.10
Extreme 0.1
1.56
More quotes

Managers and Directors - Izotropic Corporation

Managers TitleAgeSince
Robert Louis Thast CEO
 Chief Executive Officer 71 19/16/19
Ralph Proceviat DFI
 Director of Finance/CFO 73 18/19/18
Younes Achkire COO
 Chief Operating Officer - 30/21/30
Members of the board TitleAgeSince
Ralph Proceviat DFI
 Director of Finance/CFO 73 18/19/18
Alexander Tokman BRD
 Director/Board Member 62 11/22/11
Robert Louis Thast CEO
 Chief Executive Officer 71 19/16/19
More insiders

Quotes

Date Price Change Volume
26/24/26 0.14 +21.74% 6,500
25/24/25 0.115 -14.81% 4,500
24/24/24 0.135 +17.39% 61,461
23/24/23 0.115 -8.00% 24,050

Delayed Quote Canadian Securities Exchange, April 27, 2024 at 12:32 am IST

More quotes

Company Profile

Izotropic Corporation is a Canada-based medical device company. The Company is commercializing IzoView, a computed tomography (CT) imaging system, which produces images of anatomy for non-invasive tissue characterization with the first application in breast imaging. The Company has not generated any revenue.
Sector
Advanced Medical Equipment & Technology
Calendar
23/08/2024 - Q4 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Medical Imaging Systems

1st Jan change Capi.
IZOTROPIC CORPORATION Stock Izotropic Corporation
+40.00% 5.62M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. Stock Shanghai United Imaging Healthcare Co., Ltd.
-5.77% 14.68B
IRAY TECHNOLOGY COMPANY LIMITED Stock iRay Technology Company Limited
-40.71% 2.71B
SONOSCAPE MEDICAL CORP. Stock SonoScape Medical Corp.
-12.92% 2.44B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Wandong Medical Technology Co.,Ltd.
-8.78% 1.51B
CORETAG, INC. Stock Coretag, Inc.
-.--% 1.12B
NANO-X IMAGING LTD. Stock Nano-X Imaging Ltd.
+40.66% 518M
GUERBET Stock Guerbet
+91.79% 502M
VIEWORKS CO., LTD. Stock Vieworks Co., Ltd.
+1.67% 183M
INTROMEDIC CO., LTD. Stock IntroMedic Co., Ltd.
-.--% 168M
Medical Imaging Systems
  1. Stock Market
  2. Equities
  3. IZO Stock